GENERIC NAME: UROKINASE - INJECTION (you-row-KYE-naze)
BRAND NAME(S): Abbokinase
WARNING: Internal bleeding may be more difficult to control with this medication than with other anticoagulant therapy. This medication must be used in a hospital setting. It should be started as soon as possible after lung blood clots have been noticed (pulmonary embolism), preferably within 7 days. Urokinase should be given within 6 hours of the first symptoms of a heart attack associated with evolving myocardial infarction.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
Back to Medications Index